Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by KERLEAU, J. M.
Right arrow Articles by COURTOIS, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KERLEAU, J. M.
Right arrow Articles by COURTOIS, H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1994 British Society for Rheumatology

research-article

PREVALENCE AND EVOLUTION OF ANTICARDIOLIPIN ANTIBODIES IN GIANT CELL ARTERITIS DURING CORTICOSTEROID THERAPY. A PROSPECTIVE STUDY OF 20 CONSECUTIVE CASES

J. M. KERLEAU*, H. LÉVESQUE{dagger},, A. DELPECH{ddagger}, N. CAILLEUX{dagger}, P. CHASSAGNE§, O. MEJJAD{dagger}, N. D. MANCHON*, E. BERCOFF§, F. TRON{ddagger} and H. COURTOIS{dagger}

*Clinique Médicale
{dagger}Service de Médecine Inteme-Angéiologie
{ddagger}Laboratoire d'immunologie
§Service de Médecine Gértatrique CHU Rouen, 76031 Rouen, France

Correspondence to: Correspondence to: H. Lévesque, Service de Médecine Interne-Angéiologie, CHU Rouen, 76031 Rouen, France.

IgG and IgM anticardiolipin antibodies (aCA) were studied prospectively in 20 consecutive patients (12 females, eight males, mean age 74.6 ± 14 yr, range 62–86 yr) with giant cell temporal arteritis before and during corticosteroid therapy (days 7, 30, 90 and 180). IgG-aCA were present in 10 out of 20 cases and in nine out of 12 with positive temporal artery biopsy but were not found in 20 paired control subjects. During steroid therapy aCA levels returned to within the normal range in 60% of patients with positive aCA at day 7 and in 80% at day 30. In two cases aCA persisted during the 6-month follow-up despite clinical and biological success. No association was found between aCA and thrombotic events.

KEY WORDS: Temporal arteritis, Giant cell arteritis, Anticardiolipin antibodies.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
E. Liozon, P. Roblot, D. Paire, V. Loustaud, F. Liozon, E. Vidal, and M. O. Jauberteau
Anticardiolipin antibody levels predict flares and relapses in patients with giant-cell (temporal) arteritis. A longitudinal study of 58 biopsy-proven cases
Rheumatology, October 1, 2000; 39(10): 1089 - 1094.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
A. Ruffatti, C. Montecucco, D. Volante, T. Del Ross, T. Sartori, E. Rapizzi, and S. Todesco
Antiphospholipid antibody syndrome and polymyalgia rheumatica/giant cell arteritis
Rheumatology, May 1, 2000; 39(5): 565 - 567.
[Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.